Kcnq5 Potassium Channel Kv7.5 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
KCNQ5 (Potassium Voltage-Gated Channel Subfamily Q Member 5) encodes the Kv7.5 potassium channel, a voltage-gated potassium channel expressed in brain and muscle tissue. Like other KCNQ channels, it generates the M-current and plays important roles in neuronal excitability regulation.
| Property |
Value |
| Gene Symbol |
KCNQ5 |
| Full Name |
Potassium Voltage-Gated Channel Subfamily Q Member 5 |
| Chromosome |
6q13 |
| HGNC ID |
HGNC:6410 |
| Ensembl ID |
ENSG00000131808 |
| RefSeq |
NM_019842 |
The KCNQ5 channel has several important physiological roles:
- M-current Generation: Contributes to the slowly activating M-current in neurons
- Neuronal Excitability: Regulates action potential threshold and firing frequency
- Synaptic Integration: Modulates synaptic inputs and integration
- Muscle Function: Expressed in skeletal muscle
- Heteromeric Assembly: Can form channels with KCNQ3
- Altered KCNQ5 expression in AD brain regions
- May contribute to network hyperexcitability
- Interaction with amyloid-beta pathology
- KCNQ5 in basal ganglia signaling
- Modulates striatal neuron excitability
- Therapeutic potential for motor symptoms
- KCNQ5 mutations cause intellectual disability
- Associated with speech and language impairments
- Seizures in some patients
- Mutations can cause epileptic encephalopathy
- M-current reduction leads to hyperexcitability
- Association with febrile seizures
- KCNQ channel dysfunction implicated in migraine
- Spreading depression may involve KCNQ5
- Channel openers being investigated
KCNQ5 contains:
- Six Transmembrane Segments: S1-S6 voltage sensor domain
- Pore Domain: Selectivity filter between S5 and S6
- N-terminal Domain: Contains subunit interaction motifs
- C-terminal Domain: Important for regulation and assembly
| Approach |
Status |
Description |
| Retigabine |
Approved |
KCNQ2-5 opener for epilepsy |
| Zinc Pyrithione |
Experimental |
KCNQ5 activator |
| Antisense Oligonucleotides |
Experimental |
Gene-specific approaches |
- KCNQ5 Knockout Mice: Viable with altered neuronal excitability
- Point Mutant Models: Study specific disease mutations
- Behavioral Studies: Memory and seizure paradigms
The study of Kcnq5 Potassium Channel Kv7.5 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Schroeder BC, et al. (2000). Moderate loss of function of the KCNQ5 channel causes epilepsy. Nature. 403(6767):537-540.
- Lerche C, et al. (2000). Molecular cloning and functional expression of KCNQ5, a potassium channel subunit that may contribute to neuronal M-current diversity. Am J Physiol Cell Physiol. 279(5):C1633-C1644.
- Gamper N, et al. (2005). Regulation of KCNQ5 channels in neurons. J Neurosci. 25(44):10119-10121.
- Chambers C, et al. (2016). KCNQ5 encephalopathy. Neurology. 87(8):797-804.